New study explores urinary management in people with spinal cord injury
Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
Read moreAll news
Rethink Medical awarded €1.56M CDTI funding following EIC Seal of Excellence
Rethink Medical has been awarded a €1.56 million grant from the Center for Industrial Technological Development (CDTI).
The grant follows the Seal of Excellence achieved in the EIC Accelerator Program (Horizon Europe).
The duration will be two years and the funds will be used mainly for the development of the company's first device, the T-Control® urinary catheter.
With this support, Rethink Medical continues advancing the development of T-Control® as a medical-device innovation focused on urinary catheterisation.
More news
Rethink Medical presents T-Control® at the 48th Spanish Neuroscience Nursing Congress
Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.
Read more
Rethink Medical reaches the minimum target of its 2026 investment round
Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.
Read more